MENU

Immunity, Aging and COVID-19 : where do we stand?

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Bowman Professor and Head, Department of Immunobiology, Co-Director, University of Arizona Center on Aging, University of Arizona College of Medicine-Tucson
    Biography

      Dr. Nikolich-Zugich is internationally recognized as a leading immunologist and gerontologist. He received his M.D., MSc and Ph.D. in Immunology from Belgrade University and did his postdoc at the Scripps Clinic and Research Foundation with Dr. M.J. Bevan, FRS, NAS, HHMI. He held faculty positions concurrently at the  Memorial Sloan-Kettering Cancer Center, and the Cornell University Graduate School of Medical Sciences, and then at the Oregon Health and Sciences University. From 2008 he is serving as, Bowman Professor and Head, University of Arizona Department of Immunobiology and the Arizona Center on Aging (co-Director).  He is Fellow of the Gerontological Society of America and the American Aging Association. Dr Nikolich investigates, in mouse and human models: (i) basic mechanisms of immunity and how these mechanisms decline and deteriorate with age to erode protective immunity against infection; (ii) how persistent infections such as cytomegalovirus (CMV), modulate immunity and healthspan with aging; (iii) how we can devise methods to correct or ameliorate immune dysfunction by means of new vaccines, immunomodulatory and metabolic intervention and/or immune rejuvenation; and (iv) whether and how different longevity extension treatments can improve function of the immune system while still providing longevity/healthspan benefit.


    Abstract

    SARS-CoV-2 had spread with speed unknown in recent history across the globe, sickening >50M people and killing over 1M.  By far the most of the severe cases and deaths were registered amongst adults older than 65, and often older than 50 years. We will discuss what makes this virus so well suited to disperse and infect so many and be so dangerous to older adults.

    Learning Objectives:

    1. Discuss what is SARS-CoV-2 and how is it different from other coronaviruses

    2. Delineate the disease that this virus produces and what is unexpected in it

    3. Review the immune response to this virus in adult and older populations, including  duration of immunity, and discuss potential immune vulnerability and protection by vaccination


    Show Resources
    You May Also Like
    DEC 03, 2020 4:30 PM PST
    C.E. CREDITS
    DEC 03, 2020 4:30 PM PST
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    APR 01, 2021 8:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    APR 01, 2021 8:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
    FEB 24, 2021 10:00 AM PST
    C.E. CREDITS
    FEB 24, 2021 10:00 AM PST
    DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
    Loading Comments...
    Show Resources
    Attendees
    • See more